| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.053 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |